Paul Peter Tak Candel Therapeutics, Inc. (CADL) insider trading activity

CADL Quotes by TradingView

Paul Peter Tak is Chief Executive Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 343,635 shares of CADL, which is worth approximately $1.57 Million. The most recent transaction as insider was on Nov 21, 2024, when has been sold 12,900 shares (Common Stock) at a price of $1.55 per share, resulting in proceeds of $19,995. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 344K
3.9% 3M change
738.44% 12M change
Total Value Held $1.57 Million

Paul Peter Tak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 21 2024
BUY
Exercise of conversion of derivative security
$19,995 $1.55 p/Share
12,900 Added 3.62%
343,635 Common Stock
Jul 17 2024
SELL
Open market or private sale
$145,756 $6.47 p/Share
22,528 Reduced 6.38%
330,735 Common Stock
Jul 11 2024
SELL
Open market or private sale
$121,149 $5.97 p/Share
20,293 Reduced 5.43%
353,263 Common Stock
Nov 28 2023
SELL
Payment of exercise price or tax liability
$39,098 $0.9 p/Share
43,443 Reduced 10.42%
373,556 Common Stock
Nov 26 2023
BUY
Grant, award, or other acquisition
-
180,108 Added 30.16%
416,999 Common Stock
Dec 09 2022
BUY
Open market or private purchase
$24,835 $1.92 p/Share
12,935 Added 23.99%
40,985 Common Stock
Dec 08 2022
BUY
Open market or private purchase
$5,185 $1.7 p/Share
3,050 Added 9.81%
28,050 Common Stock
Nov 28 2022
BUY
Grant, award, or other acquisition
-
195,906 Added 47.0%
220,906 Common Stock
Jul 29 2021
BUY
Open market or private purchase
$200,000 $8.0 p/Share
25,000 Added 50.0%
25,000 Common Stock
PPT

Paul Peter Tak

Chief Executive Officer
Needham, MA

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CADL